1 results match your criteria: "CEFAT.Unipv - University of Pavia at Centro di Ricerca SAVE Studi[Affiliation]"
Administrative Databases and Diagnostic Therapeutic and Assistance Paths -PDTA- in the Monitoring Treatment of Rheumatoid Arthritis: The Experience of ATS Pavia.
Pragmat Obs Res
April 2023
Department of Drug Sciences, Center of Pharmaceuticals Economics and Medical Technologies Evaluation, CEFAT.Unipv - University of Pavia at Centro di Ricerca SAVE Studi, Milano, Italy.
Article Synopsis
- The study looks at how different types of medications, called biological drugs and biosimilars, affect health care costs for patients with certain diseases, especially in rheumatology.
- Researchers examined 145 patients and found that most were using the original biological drugs instead of the biosimilars, even though patients using biosimilars showed better adherence to treatment.
- The total health costs for these patients over one year was quite high, with a large portion going toward medications, and the study suggests that better communication among health professionals could help more people use biosimilars.